ALS is a progressive neurodegenerative disease that currently has no cure. Commonly known as Lou Gehrig’s disease, ALS ...

Cases of flu-like illnesses and viral infections have been on the rise in the city in recent weeks, with recovery periods ...

Q4 2024 Earnings Call Transcript February 13, 2025 Blueprint Medicines Corporation misses on earnings expectations. Reported ...

Ravijyot Saggu explores key updates and implications of the new joint chronic asthma guidelines for diagnosis and monitoring.

Researchers have found in a new study that patients with severe asthma beginning inhaled corticosteroid therapy (ICS) after decades delay exhibit different lung function trajectories. ICS is ...

The NHS has been under pressure from a ‘quad-demic’ of seasonal illnesses this winter. If you find yourself unwell it can be ...

From seasonal irritations to serious health indicators, medical experts explain the hidden meanings behind different types of ...

Early signs of whooping cough in adults look very much like a common cold, Dr. Loafman says. For the first week or so of ...

Collectively, the top eight blockbuster drugs of 2024 generated over $116 billion in sales last year. Looking closer at these ...

Akeso, Inc. (9926. HK) ('Akeso' or the 'Company') is pleased to announce the acceptance of its Investigational New Drug (IND) application by the China National Medical Products Administration (NMPA) ...

The US Food and Drug Administration has approved Symbravo (meloxicam and rizatriptan) for the acute treatment of migraine with or without aura in adults.